PURPLE BIOTECH LTD-ADR (PPBT) Fundamental Analysis & Valuation

NASDAQ:PPBT • US74638P1093

Current stock price

4.26 USD
+0.03 (+0.71%)
Last:

This PPBT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. PPBT Profitability Analysis

1.1 Basic Checks

  • PPBT had negative earnings in the past year.
  • In the past year PPBT has reported a negative cash flow from operations.
  • PPBT had negative earnings in each of the past 5 years.
  • In the past 5 years PPBT always reported negative operating cash flow.
PPBT Yearly Net Income VS EBIT VS OCF VS FCFPPBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -8.32%, PPBT is in the better half of the industry, outperforming 70.83% of the companies in the same industry.
  • With a decent Return On Equity value of -9.92%, PPBT is doing good in the industry, outperforming 73.96% of the companies in the same industry.
Industry RankSector Rank
ROA -8.32%
ROE -9.92%
ROIC N/A
ROA(3y)-34.7%
ROA(5y)-32.74%
ROE(3y)-42.11%
ROE(5y)-37.99%
ROIC(3y)N/A
ROIC(5y)N/A
PPBT Yearly ROA, ROE, ROICPPBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for PPBT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PPBT Yearly Profit, Operating, Gross MarginsPPBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2K -4K -6K -8K -10K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. PPBT Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for PPBT has been increased compared to 1 year ago.
  • The number of shares outstanding for PPBT has been increased compared to 5 years ago.
  • The debt/assets ratio for PPBT has been reduced compared to a year ago.
PPBT Yearly Shares OutstandingPPBT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
PPBT Yearly Total Debt VS Total AssetsPPBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • PPBT has an Altman-Z score of -0.90. This is a bad value and indicates that PPBT is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -0.90, PPBT is in line with its industry, outperforming 45.83% of the companies in the same industry.
  • A Debt/Equity ratio of 0.00 indicates that PPBT is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.00, PPBT is in the better half of the industry, outperforming 61.98% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.9
ROIC/WACCN/A
WACCN/A
PPBT Yearly LT Debt VS Equity VS FCFPPBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • PPBT has a Current Ratio of 1.78. This is a normal value and indicates that PPBT is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of PPBT (1.78) is worse than 67.71% of its industry peers.
  • PPBT has a Quick Ratio of 1.78. This is a normal value and indicates that PPBT is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.78, PPBT is in line with its industry, outperforming 41.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.78
PPBT Yearly Current Assets VS Current LiabilitesPPBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. PPBT Growth Analysis

3.1 Past

  • PPBT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 85.67%, which is quite impressive.
EPS 1Y (TTM)85.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PPBT Yearly Revenue VS EstimatesPPBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 200K 400K 600K 800K

More info and screens

Find the best growth stocksShow best growing peers

0

4. PPBT Valuation Analysis

4.1 Price/Earnings Ratio

  • PPBT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PPBT Price Earnings VS Forward Price EarningsPPBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PPBT Per share dataPPBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PPBT Dividend Analysis

5.1 Amount

  • No dividends for PPBT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PPBT Fundamentals: All Metrics, Ratios and Statistics

PURPLE BIOTECH LTD-ADR

NASDAQ:PPBT (4/9/2026, 3:38:26 PM)

4.26

+0.03 (+0.71%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-03
Earnings (Next)05-19
Inst OwnersN/A
Inst Owner Change488.74%
Ins OwnersN/A
Ins Owner Change0%
Market Cap38.47M
Revenue(TTM)N/A
Net Income(TTM)-3.25M
Analysts0
Price TargetN/A
Short Float %N/A
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.17
P/tB 7.8
EV/EBITDA N/A
EPS(TTM)-0.43
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.73
FCFYN/A
OCF(TTM)-0.73
OCFYN/A
SpS0
BVpS3.63
TBVpS0.55
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.32%
ROE -9.92%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-34.7%
ROA(5y)-32.74%
ROE(3y)-42.11%
ROE(5y)-37.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 1.78
Altman-Z -0.9
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)38.32%
Cap/Depr(5y)46.22%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)85.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y68.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y65.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y65.53%
OCF growth 3YN/A
OCF growth 5YN/A

PURPLE BIOTECH LTD-ADR / PPBT Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for PURPLE BIOTECH LTD-ADR?

ChartMill assigns a fundamental rating of 1 / 10 to PPBT.


What is the valuation status for PPBT stock?

ChartMill assigns a valuation rating of 0 / 10 to PURPLE BIOTECH LTD-ADR (PPBT). This can be considered as Overvalued.


Can you provide the profitability details for PURPLE BIOTECH LTD-ADR?

PURPLE BIOTECH LTD-ADR (PPBT) has a profitability rating of 1 / 10.